Cadrenal Therapeutics, Inc.
These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.
Filing history at a glance
The reported offering amount was $7,923,235 in the Apr 6, 2026 filing and $8,843,849 in the Jul 15, 2026 filing. The two records may concern different offerings. All 3 stored filings from Dec 31, 2025 to Jul 15, 2026 are original notices.
through Jul 15, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Differences between reported disclosures
Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.
| Field | Apr 6, 2026 · D | Jul 15, 2026 · D | Later minus earlier |
|---|---|---|---|
| Reported offering amount | $7,923,235 | $8,843,849 | $920,614 |
| Reported amount sold | $7,923,235 | $8,843,849 | $920,614 |
| Reported investor count | — | 1 | — |
| Reported minimum investment | $0 | $0 | $0 |
Earlier SEC source: 0001213900-26-040457 · Later SEC source: 0001213900-26-078373
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot: how to read these fields
- Reported offering amount
- $8,843,849
- Reported exemptions
- Rule 506(b)
- Reported amount sold
- $8,843,849
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Filings by year
- 20251 filing
- 20262 filings
Submission counts, including amendments; not dollars raised or distinct funding rounds.
Shared EDGAR submitting account
These filings share an external submitting CIK in their accession numbers. The account may belong to a filing agent. How EDGAR assigns accession numbers.
- Nok Therapeutics, Inc. · CIK 2038166
- Sharrow Engineering, Inc. · CIK 1847166
- Hygia Technologies, Inc. · CIK 2085068
- VitaNav Inc. · CIK 2108556
- Palmer Square Multi-Asset Credit Offshore Fund L.P. · CIK 2010639
Form D filings (3)
-
0001213900-26-078373D · Jul 15, 2026 · BiotechnologyOffering: $8,843,849Sold: $8,843,849
Compared with 0001213900-26-040457:
- Reported offering amount: $7,923,235 → $8,843,849
- Reported amount sold: $7,923,235 → $8,843,849
- Reported investor count: Unavailable → 1
-
0001213900-26-040457D · Apr 6, 2026 · BiotechnologyOffering: $7,923,235Sold: $7,923,235
Compared with 0001213900-25-127129:
- Reported offering amount: $4,396,329 → $7,923,235
- Reported amount sold: $4,396,329 → $7,923,235
-
0001213900-25-127129D · Dec 31, 2025 · BiotechnologyOffering: $4,396,329Sold: $4,396,329